Table 1

 Costs and survival of 80 children treated with extracorporeal membrane oxygenation (ECMO)

TotalECMO survivalHospital survival12 month survivalMedian 5-year costs (€)Total costs (€)Cost per life saved (€)
Costs and survival of 80 children treated with ECMO in the period 1997–2002. The patient age at initiation of ECMO was classified as neonatal (0–28 days), infant (28 days–18 months), or paediatric (>18 months), and the indication for ECMO was classified as respiratory, congenital heart disease, or acquired heart disease (myocarditis or cardiomyopathy). Children who received a cardiac transplant while receiving ECMO are represented in the cardiac transplant rescue category. Values are number (%).
*One congenital diaphragmatic hernia, three meconium aspiration, three persistent pulmonary hypertension, two alveolar capillary dysplasia.
†Wegener’s syndrome, pneumonitis, lung transplant, Bordetella pertussis.
¶p  =  0·002 compared with children not receiving cardiac transplantation (Wilcoxon rank sum test).
All8047 (59)31 (39)29 (36)40 9355 117 551176 467
Congenital heart disease5533 (60)19 (35)16 (29)43 9433 819 204238 700
Myocarditis/cardiomyopathy75 (71)5 (71)5 (71)68 877559 582111 916
Neonatal respiratory*94 (44)3 (33)3 (33)28 632276 97792 326
Paediatric or infant respiratory†43 (75)3 (75)3 (75)65 894371 695121 665
Neonates3220 (63)13 (41)12 (38)41 6202 410 026200 835
Infants2715 (56)7 (26)4 (15)34 3861 188 019297 004
Paediatric2112 (57)11 (52)10 (48)48 5801 519 507151 951
Cardiac transplant rescue87 (88)7 (88)6 (75)149 212¶1 193 089198 848